Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
330 participants
OBSERVATIONAL
2020-06-10
2024-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparing the Clinical Characteristics of Male LADA, T1DM and T2DM Patients
NCT04618354
Stressors, Coping Methods and Social Support in Diabetic Patients
NCT01159184
Clinical Characteristics of People With Long-term Type 1 Diabetes
NCT05359796
Changes in Skin Innervation of Neurologically Asymptomatic Type 2 Diabetic Patients: the Correlation With the Diabetic Parameters and Neurotrophins.
NCT00155142
Prevalence and Determinants of Subclinical Cardiovascular Dysfunction in Adults With Type 2 Diabetes Mellitus
NCT03132129
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
T2DM with OSA
Type 2 diabetes patients with obstructive sleep apnea
regular treatment
The patients with or without OSA received regular hypoglycemic drugs.
T2DM without OSA
Type 2 diabetes patients without obstructive sleep apnea
regular treatment
The patients with or without OSA received regular hypoglycemic drugs.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
regular treatment
The patients with or without OSA received regular hypoglycemic drugs.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ageļ¼18-80
Exclusion Criteria
* Preparation for pregnancy
* Lactation patients
* Patients with uncontrolled thyroid disease
* Patients with severe cardiovascular disease
* Patients with severe hepatic and renal insufficiency
* Patients with oral and maxillofacial malformations and upper respiratory tract malformations
* Patients with pulmonary infection or COPD
* Patients who are not willing to accept the questionnaire survey
* Unable to sign informed consent
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The First Affiliated Hospital of Xiamen University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The first affiliated hospital of Xiamen university
Xiamen, Fujian, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-025
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.